+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurovascular Intervention Devices Market - Global Forecast 2026-2032- Product Image
Neurovascular Intervention Devices Market - Global Forecast 2026-2032- Product Image
Sale

Neurovascular Intervention Devices Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674201
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Neurovascular Intervention Devices Market is projected to reach USD 4.84 Billion in 2026. It is expected to continue growing at a CAGR of 6.69%, reaching USD 7.14 Billion by 2032.

The neurovascular intervention devices landscape is expanding as stroke and intracranial aneurysm care moves from pharmacologic-only treatment toward time-sensitive, image-guided endovascular therapy. The World Stroke Organization and Global Burden of Disease data identify stroke as one of the leading global causes of death and long-term disability, with more than 12 million new strokes and over 6 million stroke-related deaths reported annually. This disease burden supports sustained clinical demand for stent retrievers, aspiration catheters, embolization coils, flow diverters, intrasaccular devices, neurovascular stents, guidewires, microcatheters, balloon catheters, and vascular access systems.

Clinical adoption is underpinned by randomized evidence showing that mechanical thrombectomy improves functional outcomes in eligible large vessel occlusion stroke, including selected patients treated beyond the traditional early treatment window when advanced imaging confirms salvageable brain tissue. Hospitals, device manufacturers, clinicians, and payers are therefore prioritizing faster diagnosis, organized stroke networks, and neurovascular devices that improve deliverability, recanalization, procedural safety, and workflow efficiency.

Transformative Shifts in the Neurovascular Device Landscape

The neurovascular intervention devices landscape is being reshaped by the convergence of minimally invasive therapy, advanced neuroimaging, and formalized stroke systems of care. Mechanical thrombectomy has shifted acute ischemic stroke treatment toward rapid endovascular access for appropriate large vessel occlusion cases, while newer aneurysm technologies such as flow diversion, intrasaccular embolization, and adjunctive stenting are broadening treatment options for complex, bifurcation, and wide-neck intracranial aneurysms.

Regulatory and procurement expectations are also changing. The European Medical Device Regulation has raised clinical evidence, risk management, and post-market surveillance requirements, while U.S. FDA pathways continue to emphasize safety, performance, labeling accuracy, and real-world monitoring. At the same time, hospitals are consolidating neurointerventional services into high-volume comprehensive stroke centers and thrombectomy-capable networks, placing greater value on device compatibility, physician training support, inventory reliability, imaging integration, and measurable clinical outcomes.

Cumulative Impact of Artificial Intelligence in Neurovascular Care

Artificial intelligence is creating a cumulative impact across the neurovascular care pathway rather than acting as a single-point technology. FDA-authorized AI-enabled radiology tools increasingly support detection and triage of large vessel occlusion, intracranial hemorrhage, and perfusion abnormalities, helping care teams shorten door-to-image, image-to-notification, and image-to-intervention decision cycles in acute stroke workflows.

Beyond triage, AI is being applied to vessel segmentation, clot characterization, aneurysm measurement, procedural planning, robotics research, case prioritization, quality reporting, and post-market performance analytics. The strongest commercial opportunities will come from validated AI that integrates with PACS, stroke communication platforms, electronic health records, and cath lab workflows. Industry leaders must also address algorithmic bias, cybersecurity, explainability, data governance, and evidence generation because AI performance can vary across scanners, imaging protocols, patient populations, and clinical settings.

Key Regional Insights: Asia-Pacific, North America, Europe, and Emerging Regions

North America remains a high-adoption region for neurovascular intervention devices due to mature stroke center networks, broad availability of CT angiography and perfusion imaging, established reimbursement channels, and strong participation in neurovascular clinical research. Europe combines sophisticated neurointerventional practice with stricter evidence expectations under the Medical Device Regulation, creating opportunities for clinically differentiated thrombectomy, embolization, and aneurysm treatment technologies that can demonstrate safety, durability, usability, and health-system value.

Asia-Pacific carries a substantial share of the global stroke burden, with China, India, Japan, South Korea, and Australia shaping demand through different combinations of public investment, specialist availability, imaging infrastructure, and reimbursement maturity. Latin America is led by Brazil and Mexico but remains uneven in access to thrombectomy-capable hospitals and trained neurointerventional specialists. The Middle East, particularly advanced Gulf health systems, is investing in tertiary hospitals, digital health, and stroke service modernization, while Africa represents a long-term access opportunity constrained by limited advanced imaging capacity, specialist shortages, referral delays, and affordability barriers.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are moving toward stronger stroke referral pathways and greater adoption of endovascular stroke treatment, but implementation differs widely between Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines because of reimbursement models, urban-rural access, hospital infrastructure, and interventional workforce capacity. GCC countries are investing in tertiary care hospitals, digital health infrastructure, specialist recruitment, and international clinical standards, which supports demand for premium neurovascular technologies in centers of excellence.

The European Union is defined by MDR compliance, stronger clinical evidence expectations, coordinated health technology assessment trends, and sophisticated hospital procurement. BRICS countries represent major procedure-volume potential because of high stroke burden and expanding hospital capacity, but pricing, local manufacturing, public purchasing, and reimbursement inclusion are decisive. G7 markets remain central to innovation, guideline development, clinical trial leadership, and early adoption of advanced neurovascular devices, while NATO countries increasingly frame medical supply resilience, secure procurement, and domestic capacity as healthcare security priorities.

Key Country Insights Across Major Neurovascular Markets

The United States is a leading innovation and adoption hub, supported by comprehensive stroke center certification, FDA-reviewed neurovascular devices, advanced imaging access, and strong clinical trial infrastructure, while Canada emphasizes equitable access across provincial health systems and regionalized stroke care pathways. Mexico and Brazil are expanding neurointerventional capability, though access to mechanical thrombectomy and aneurysm embolization remains concentrated in major urban hospitals and private or tertiary public centers.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine mature specialist networks with increasing scrutiny of clinical evidence, procurement value, and post-market performance, while Russia presents demand shaped by public investment, regional infrastructure differences, and access variability. China is scaling domestic and imported neurovascular technologies alongside high stroke volumes and expanding hospital capabilities; India offers substantial long-term clinical need but remains highly price-sensitive with uneven access outside large metropolitan centers. Japan and South Korea are advanced adopters with strong imaging infrastructure, specialist capacity, and aging populations that increase cerebrovascular disease management needs, while Australia benefits from organized stroke networks, aeromedical referral pathways, and telehealth-enabled coordination across geographically dispersed communities.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-backed differentiation in neurovascular intervention devices. Products that improve first-pass reperfusion, reduce procedure time, enhance trackability through tortuous anatomy, lower complication risk, and demonstrate durable aneurysm occlusion will command stronger clinical attention than devices positioned only on incremental design changes.

Manufacturers should build integrated offerings around physician training, AI-enabled workflow partnerships, inventory planning, and real-world evidence generation. Commercial teams should segment markets by stroke network maturity, reimbursement readiness, imaging access, and specialist density. In emerging markets, affordability, local partnerships, physician education, service support, and reliable supply chains are critical. Across all regions, leaders should prepare for tighter post-market surveillance, cybersecurity expectations for connected systems, and stronger proof of clinical and health-economic value.

Research Methodology

This executive summary is based on a structured methodology combining verified secondary research, regulatory review, clinical literature assessment, and market triangulation. Sources considered include peer-reviewed stroke and neurointervention studies, World Stroke Organization and Global Burden of Disease findings, FDA and European regulatory information, hospital care pathway standards, reimbursement references, clinical guideline documents, and publicly available healthcare infrastructure indicators.

Insights were validated through cross-checking of disease burden, technology adoption drivers, regulatory trends, care delivery models, and regional healthcare infrastructure indicators. The analysis emphasizes evidence-supported directionality rather than unsupported numerical forecasts, ensuring that conclusions reflect clinically grounded and commercially relevant developments in neurovascular intervention devices.

Conclusion

Neurovascular intervention devices are becoming central to modern stroke and intracranial aneurysm care as health systems prioritize faster diagnosis, minimally invasive treatment, and measurable patient outcomes. The landscape is supported by a large cerebrovascular disease burden, proven thrombectomy benefits in selected large vessel occlusion patients, continued aneurysm device innovation, and growing use of artificial intelligence to accelerate imaging triage and treatment coordination.

Competitive advantage will depend on clinical evidence, procedural performance, regulatory readiness, supply reliability, and the ability to support organized stroke systems across both mature and emerging healthcare markets. Organizations that align product innovation with real-world workflow, physician training, data-driven quality improvement, and access expansion will be best positioned for sustainable growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Neurovascular Intervention Devices Market, by Product Type
7.1. Introduction
7.2. Embolic Agents
7.2.1. Liquid Embolics
7.2.2. Particulate Embolics
7.3. Flow Diverters
7.3.1. Pipeline Embolization Device
7.3.2. Surpass Flow Diverter
7.4. Microcatheters
7.4.1. Hydrophilic Coated
7.4.2. Polymer Coated
7.5. Neurovascular Coils
7.5.1. Detachable Coils
7.5.2. Pushable Coils
7.6. Stents
7.6.1. Balloon Mounted
7.6.2. Self Expanding
7.7. Thrombectomy Devices
7.7.1. Aspiration Devices
7.7.2. Stent Retriever
8. Neurovascular Intervention Devices Market, by Indication
8.1. Introduction
8.2. Aneurysm
8.3. Arteriovenous Malformation
8.4. Stroke
9. Neurovascular Intervention Devices Market, by Procedure Type
9.1. Introduction
9.2. Embolization
9.3. Flow Diversion
9.4. Thrombectomy
10. Neurovascular Intervention Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Centers
10.3. Clinics
10.4. Hospitals
11. Neurovascular Intervention Devices Market, by Region
11.1. Asia-Pacific
11.2. North America
11.3. Latin America
11.4. Europe
11.5. Middle East
11.6. Africa
12. Neurovascular Intervention Devices Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Neurovascular Intervention Devices Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Acandis GmbH
15.3. Achieva Medical Co Ltd
15.4. Asahi Intecc Co Ltd
15.5. Balt Group
15.6. Boston Scientific Corporation
15.7. Cerus Endovascular Ltd
15.8. Evasc Neurovascular Enterprises
15.9. Imperative Care Inc
15.10. InspireMD Inc
15.11. Integer Holdings Corporation
15.12. Kaneka Corporation
15.13. Lepu Medical Technology Beijing Co Ltd
15.14. Medtronic plc
15.15. Merit Medical Systems Inc
15.16. MicroPort Scientific Corporation
15.17. NeuroSafe Medical Co Ltd
15.18. NeuroVasc Technologies Inc
15.19. Penumbra Inc
15.20. Perflow Medical Ltd
15.21. Rapid Medical Ltd
15.22. Shanghai HeartCare Medical Technology Corporation Ltd
15.23. Shape Memory Medical Inc
15.24. Stryker Corporation
15.25. Teleflex Incorporated
15.26. Terumo Corporation
15.27. Vesalio LLC
15.28. Wallaby Medical
15.29. Zylox-Tonbridge Medical Technology Co Ltd
List of Figures
FIGURE 1. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL EMBOLIC AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL EMBOLIC AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL EMBOLIC AGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL LIQUID EMBOLICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL LIQUID EMBOLICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL LIQUID EMBOLICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PARTICULATE EMBOLICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PARTICULATE EMBOLICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PARTICULATE EMBOLICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL FLOW DIVERTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL FLOW DIVERTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL PIPELINE EMBOLIZATION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL PIPELINE EMBOLIZATION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL PIPELINE EMBOLIZATION DEVICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL SURPASS FLOW DIVERTER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL SURPASS FLOW DIVERTER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL SURPASS FLOW DIVERTER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL MICROCATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL MICROCATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL MICROCATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL HYDROPHILIC COATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL HYDROPHILIC COATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL HYDROPHILIC COATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL POLYMER COATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL POLYMER COATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL POLYMER COATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL NEUROVASCULAR COILS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL NEUROVASCULAR COILS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL NEUROVASCULAR COILS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL DETACHABLE COILS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL DETACHABLE COILS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL DETACHABLE COILS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL PUSHABLE COILS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL PUSHABLE COILS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL PUSHABLE COILS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL BALLOON MOUNTED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL BALLOON MOUNTED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL BALLOON MOUNTED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL SELF EXPANDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SELF EXPANDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL SELF EXPANDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ASPIRATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ASPIRATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ASPIRATION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL STENT RETRIEVER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL STENT RETRIEVER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL STENT RETRIEVER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ANEURYSM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ANEURYSM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ANEURYSM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ARTERIOVENOUS MALFORMATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ARTERIOVENOUS MALFORMATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ARTERIOVENOUS MALFORMATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL STROKE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL STROKE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL STROKE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL EMBOLIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL EMBOLIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL EMBOLIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL FLOW DIVERSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL FLOW DIVERSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL FLOW DIVERSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL THROMBECTOMY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL THROMBECTOMY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL THROMBECTOMY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL AMBULATORY CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL AMBULATORY CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL AMBULATORY CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 100. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 103. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 104. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 105. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 106. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 107. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 108. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 109. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 110. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 111. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 113. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 114. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 115. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 116. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 117. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 118. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 119. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 120. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 121. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 122. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 124. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 125. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 126. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 127. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 128. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 129. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 130. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 131. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 132. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 133. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 135. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 136. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 137. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 138. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 139. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 140. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 141. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 142. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 143. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 144. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 146. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 147. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 148. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 149. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 150. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 151. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 152. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 153. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 154. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 156. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 157. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 158. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 159. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 160. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 161. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 162. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 163. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 164. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 165. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 166. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 167. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 168. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 169. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 170. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 171. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 172. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 173. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 174. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 175. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 176. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 177. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 189. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 190. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 191. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 192. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 193. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 194. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 195. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 196. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 197. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 198. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 199. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 200. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 201. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 202. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 203. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 204. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 205. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 206. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 207. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 208. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 209. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 210. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 211. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 212. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 213. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 214. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 215. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 216. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 217. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 218. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 219. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 220. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 221. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 222. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 223. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 224. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 225. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 226. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 227. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 228. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 229. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 230. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 231. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 232. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 233. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 234. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 235. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 236. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 237. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 238. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 239. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 240. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 241. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 242. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 243. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 244. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 246. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 247. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 248. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 249. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 250. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 251. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 252. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 253. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 254. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 255. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 256. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 257. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 258. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 259. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 260. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 261. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 262. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 263. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 264. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 265. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 266. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 267. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 268. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 269. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 270. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 271. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 272. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 273. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 274. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 275. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 276. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 277. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 278. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 279. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 280. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 281. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 282. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 283. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 284. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 285. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 286. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 287. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 288. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 289. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 290. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 291. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 292. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 293. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 294. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 295. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 296. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 297. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 298. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 299. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 300. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 301. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 302. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 303. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 304. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 305. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 306. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 307. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 308. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 309. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 310. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 312. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 313. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 314. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 315. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2017-2032 (USD MILLION)
TABLE 316. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2017-2032 (USD MILLION)
TABLE 317. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 318. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 319. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 320. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 321. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 322. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 323. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE

Companies Mentioned

  • Abbott Laboratories
  • Acandis GmbH
  • Achieva Medical Co Ltd
  • Asahi Intecc Co Ltd
  • Balt Group
  • Boston Scientific Corporation
  • Cerus Endovascular Ltd
  • Evasc Neurovascular Enterprises
  • Imperative Care Inc
  • InspireMD Inc
  • Integer Holdings Corporation
  • Kaneka Corporation
  • Lepu Medical Technology Beijing Co Ltd
  • Medtronic plc
  • Merit Medical Systems Inc
  • MicroPort Scientific Corporation
  • NeuroSafe Medical Co Ltd
  • NeuroVasc Technologies Inc
  • Penumbra Inc
  • Perflow Medical Ltd
  • Rapid Medical Ltd
  • Shanghai HeartCare Medical Technology Corporation Ltd
  • Shape Memory Medical Inc
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Vesalio LLC
  • Wallaby Medical
  • Zylox-Tonbridge Medical Technology Co Ltd

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.84 Billion
Forecasted Market Value ( USD ) by 2032 $ 7.14 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Neurovascular Neurology Devices Market - Global Forecast 2026-2032 - Product Image

Neurovascular Neurology Devices Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Interventional Neurology Devices Market - Global Forecast 2026-2032 - Product Image

Interventional Neurology Devices Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Neurovascular Devices / Interventional Neurology - Global Strategic Business Report - Product Image

Neurovascular Devices / Interventional Neurology - Global Strategic Business Report

  • Report
  • 198 Pages
  • Global
From
Neurovascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Neurovascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Neurovascular Devices Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034 - Product Image

Neurovascular Devices Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034

  • Report
  • 146 Pages
  • Global
From

About the Neurovascular Intervention Device Market

The Neurovascular Intervention Device market is a subset of the Neurology Devices market, which includes a range of medical devices used to diagnose and treat neurological conditions. Neurovascular Intervention Devices are used to treat conditions such as stroke, aneurysms, and arteriovenous malformations. These devices are used to access the brain and other parts of the nervous system, and to deliver treatments such as stents, balloons, and coils. The Neurovascular Intervention Device market is highly competitive, with a range of companies offering a variety of products. Some of the major players in the market include Medtronic, Stryker, Johnson & Johnson, Boston Scientific, and Terumo Corporation. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.